Caldwell Trust CO Cel Sci Corp Transaction History

Caldwell Trust CO

  • $1.07 Trillion
  • Q3 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Oct 02, 2025
SELL
$7.1 - $12.82 $5,325 - $9,615
-750 Closed
0 $0
Q1 2021

Oct 02, 2025
BUY
$12.0 - $27.64 $9,000 - $20,730
750 New
750 $11.4 Million
Q4 2020

Oct 02, 2025
BUY
$11.05 - $16.62 $8,287 - $12,465
750 New
750 $8.75 Million
Q1 2020

Oct 02, 2025
BUY
$7.54 - $17.05 $5,655 - $12,787
750 New
750 $8.66 Million
Q4 2019

Oct 06, 2025
BUY
$6.71 - $9.55 $5,032 - $7,162
750 New
750 $6.86 Million

Others Institutions Holding CVM

# of Institutions
10
Shares Held
864K
Call Options Held
0
Put Options Held
0
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $291M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Caldwell Trust CO Portfolio

Follow Caldwell Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email